In recent years, while research in the field of diabetes has focused on alternative ways to utilize the vast knowledge on this transcription factor, FoxO1 became a relevant target in several hematological malignancies as well as in some solid tumors (see below). This evidence concerns the gene FOXO1 and diabetes mellitus.